Diclofenac Potassium + Paracetamol + ChlorzoxazoneThird Party Manufacturing in India

This triple combination brings together three complementary pharmacological agents to address the multidimensional nature of musculoskeletal pain.

Diclofenac potassium is a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase-1 and cyclooxygenase-2 enzymes, reducing the synthesis of prostaglandins and other inflammatory mediators at the site of tissue injury. This provides potent anti-inflammatory and peripheral analgesic effects. Diclofenac also inhibits the lipoxygenase pathway and activates the nitric oxide-cGMP antinociceptive pathway, contributing to its broad analgesic profile.

Paracetamol acts centrally to reduce pain and fever. Its primary mechanism involves inhibition of a brain-specific COX enzyme, reducing prostaglandin synthesis in the hypothalamus. Paracetamol also activates descending serotonergic inhibitory pathways in the spinal cord and its metabolite AM404 activates cannabinoid CB1 receptors, contributing to central pain modulation without significant peripheral anti-inflammatory effects.

Chlorzoxazone is a centrally acting skeletal muscle relaxant. It acts primarily at the level of the spinal cord and subcortical areas of the brain, where it inhibits multisynaptic reflex arcs responsible for maintaining skeletal muscle spasm. By reducing muscle spasm, chlorzoxazone helps break the pain-spasm-pain cycle, improving mobility and reducing discomfort associated with acute musculoskeletal conditions.

Together, these three mechanisms address inflammation, central pain perception, and muscle spasm simultaneously, providing comprehensive relief for patients with painful musculoskeletal conditions.

Therapeutic Uses

Diclofenac Potassium + Paracetamol + Chlorzoxazone is indicated for the treatment of:

• Acute Musculoskeletal Conditions: For painful conditions involving muscle spasm such as acute low back pain, cervical spondylosis, lumbar radiculopathy, and fibromyalgia. The combination addresses pain, inflammation, and muscle spasm simultaneously.
• Soft Tissue Injuries: For sprains, strains, ligament injuries, and sports-related trauma where both inflammatory pain and reactive muscle spasm are present.
• Post-Traumatic Pain: Following accidents or injuries that result in both soft tissue inflammation and protective muscle guarding that perpetuates pain.
• Tension Headaches and Cervical Pain: For headaches arising from neck muscle tension, where muscle relaxant action combined with analgesic and anti-inflammatory effects provides comprehensive relief.
• Post-Surgical Musculoskeletal Pain: As part of recovery protocols following orthopedic or spinal procedures where muscle spasm complicates pain management.

Why Manufacturers Choose This Combination

The Diclofenac Potassium + Paracetamol + Chlorzoxazone combination is one of the most commonly prescribed muscle relaxant combinations in the Indian pharmaceutical market. It offers a differentiated product for PCD franchise partners targeting general practice, orthopedic, and physiotherapy segments. The combination is well-established with multiple generic manufacturers competing in the market, ensuring steady raw material supply and cost-effective production. Indian contract manufacturers produce this combination in large volumes for both domestic and export markets, particularly to CIS countries, the Middle East, and Southeast Asia. The availability of both branded and generic versions creates ample opportunity for third-party manufacturing partnerships.